Selected research
Industry Research
Pharmaceutical Serialisation Services Industry Research Report 2026
Market perspective
The global Pharmaceutical Serialisation Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Serialisation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Serialisation Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Serialisation Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Serialisation Services include Movianto, UPM Pharmaceuticals, MSK Pharmalogisti, Covectra, Koerber-Pharma, Palladio Group, TraceLink, Ultimate Solutions and Clarkston Consulting, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Serialisation Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Serialisation Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Serialisation Services Market by Company
Movianto
UPM Pharmaceuticals
MSK Pharmalogisti
Covectra
Koerber-Pharma
Palladio Group
TraceLink
Ultimate Solutions
Clarkston Consulting
Jones Healthcare Group
MSK Pharmalogistic
Vetter-Pharma
NextPharma Logistics
OPTEL
Central Pharma
Aphena Pharma +C581Solutions
NNE
Sharp Services
Pharmaceutical Serialisation Services Segment by Type
Barcode
QR Code
RFID
Others
Pharmaceutical Serialisation Services Segment by Application
Pharmaceutical Manufacturing
Pharmaceutical Distribution
Pharmaceutical Logistics
Pharmaceutical Serialisation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Serialisation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Serialisation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Serialisation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Serialisation Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Barcode
- QR Code
- RFID
- Others
Applications
- Pharmaceutical Manufacturing
- Pharmaceutical Distribution
- Pharmaceutical Logistics
Companies covered
- Movianto
- UPM Pharmaceuticals
- MSK Pharmalogisti
- Covectra
- Koerber-Pharma
- Palladio Group
- TraceLink
- Ultimate Solutions
- Clarkston Consulting
- Jones Healthcare Group
- MSK Pharmalogistic
- Vetter-Pharma
- NextPharma Logistics
- OPTEL
- Central Pharma
- Aphena Pharma +C581Solutions
- NNE
- Sharp Services
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Serialisation Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Barcode
- 2.2.3 QR Code
- 2.2.4 RFID
- 2.2.5 Others
- 2.3 Pharmaceutical Serialisation Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Manufacturing
- 2.3.3 Pharmaceutical Distribution
- 2.3.4 Pharmaceutical Logistics
- 2.4 Assumptions and Limitations
3 Pharmaceutical Serialisation Services Breakdown Data by Type
- 3.1 Global Pharmaceutical Serialisation Services Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Serialisation Services Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Serialisation Services Breakdown Data by Application
- 4.1 Global Pharmaceutical Serialisation Services Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Serialisation Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Serialisation Services Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Serialisation Services Growth Trends by Region
- 5.2.1 Global Pharmaceutical Serialisation Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Serialisation Services Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Serialisation Services Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Serialisation Services Market Dynamics
- 5.3.1 Pharmaceutical Serialisation Services Industry Trends
- 5.3.2 Pharmaceutical Serialisation Services Market Drivers
- 5.3.3 Pharmaceutical Serialisation Services Market Challenges
- 5.3.4 Pharmaceutical Serialisation Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Serialisation Services Players by Revenue
- 6.1.1 Global Top Pharmaceutical Serialisation Services Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Serialisation Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Serialisation Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Serialisation Services Head Office and Area Served
- 6.4 Global Pharmaceutical Serialisation Services Players, Product Type & Application
- 6.5 Global Pharmaceutical Serialisation Services Manufacturers Established Date
- 6.6 Global Pharmaceutical Serialisation Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Serialisation Services Market Size (2021-2032)
- 7.2 North America Pharmaceutical Serialisation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Serialisation Services Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Serialisation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Serialisation Services Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Serialisation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Serialisation Services Market Size (2021-2032)
- 10.2 South America Pharmaceutical Serialisation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Serialisation Services Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Serialisation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Movianto
- 12.1.1 Movianto Company Information
- 12.1.2 Movianto Business Overview
- 12.1.3 Movianto Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.1.4 Movianto Pharmaceutical Serialisation Services Product Portfolio
- 12.1.5 Movianto Recent Developments
- 12.2 UPM Pharmaceuticals
- 12.2.1 UPM Pharmaceuticals Company Information
- 12.2.2 UPM Pharmaceuticals Business Overview
- 12.2.3 UPM Pharmaceuticals Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.2.4 UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio
- 12.2.5 UPM Pharmaceuticals Recent Developments
- 12.3 MSK Pharmalogisti
- 12.3.1 MSK Pharmalogisti Company Information
- 12.3.2 MSK Pharmalogisti Business Overview
- 12.3.3 MSK Pharmalogisti Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.3.4 MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio
- 12.3.5 MSK Pharmalogisti Recent Developments
- 12.4 Covectra
- 12.4.1 Covectra Company Information
- 12.4.2 Covectra Business Overview
- 12.4.3 Covectra Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.4.4 Covectra Pharmaceutical Serialisation Services Product Portfolio
- 12.4.5 Covectra Recent Developments
- 12.5 Koerber-Pharma
- 12.5.1 Koerber-Pharma Company Information
- 12.5.2 Koerber-Pharma Business Overview
- 12.5.3 Koerber-Pharma Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.5.4 Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio
- 12.5.5 Koerber-Pharma Recent Developments
- 12.6 Palladio Group
- 12.6.1 Palladio Group Company Information
- 12.6.2 Palladio Group Business Overview
- 12.6.3 Palladio Group Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.6.4 Palladio Group Pharmaceutical Serialisation Services Product Portfolio
- 12.6.5 Palladio Group Recent Developments
- 12.7 TraceLink
- 12.7.1 TraceLink Company Information
- 12.7.2 TraceLink Business Overview
- 12.7.3 TraceLink Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.7.4 TraceLink Pharmaceutical Serialisation Services Product Portfolio
- 12.7.5 TraceLink Recent Developments
- 12.8 Ultimate Solutions
- 12.8.1 Ultimate Solutions Company Information
- 12.8.2 Ultimate Solutions Business Overview
- 12.8.3 Ultimate Solutions Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.8.4 Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio
- 12.8.5 Ultimate Solutions Recent Developments
- 12.9 Clarkston Consulting
- 12.9.1 Clarkston Consulting Company Information
- 12.9.2 Clarkston Consulting Business Overview
- 12.9.3 Clarkston Consulting Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.9.4 Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio
- 12.9.5 Clarkston Consulting Recent Developments
- 12.10 Jones Healthcare Group
- 12.10.1 Jones Healthcare Group Company Information
- 12.10.2 Jones Healthcare Group Business Overview
- 12.10.3 Jones Healthcare Group Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.10.4 Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio
- 12.10.5 Jones Healthcare Group Recent Developments
- 12.11 MSK Pharmalogistic
- 12.11.1 MSK Pharmalogistic Company Information
- 12.11.2 MSK Pharmalogistic Business Overview
- 12.11.3 MSK Pharmalogistic Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.11.4 MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio
- 12.11.5 MSK Pharmalogistic Recent Developments
- 12.12 Vetter-Pharma
- 12.12.1 Vetter-Pharma Company Information
- 12.12.2 Vetter-Pharma Business Overview
- 12.12.3 Vetter-Pharma Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.12.4 Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio
- 12.12.5 Vetter-Pharma Recent Developments
- 12.13 NextPharma Logistics
- 12.13.1 NextPharma Logistics Company Information
- 12.13.2 NextPharma Logistics Business Overview
- 12.13.3 NextPharma Logistics Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.13.4 NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio
- 12.13.5 NextPharma Logistics Recent Developments
- 12.14 OPTEL
- 12.14.1 OPTEL Company Information
- 12.14.2 OPTEL Business Overview
- 12.14.3 OPTEL Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.14.4 OPTEL Pharmaceutical Serialisation Services Product Portfolio
- 12.14.5 OPTEL Recent Developments
- 12.15 Central Pharma
- 12.15.1 Central Pharma Company Information
- 12.15.2 Central Pharma Business Overview
- 12.15.3 Central Pharma Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.15.4 Central Pharma Pharmaceutical Serialisation Services Product Portfolio
- 12.15.5 Central Pharma Recent Developments
- 12.16 Aphena Pharma +C581Solutions
- 12.16.1 Aphena Pharma +C581Solutions Company Information
- 12.16.2 Aphena Pharma +C581Solutions Business Overview
- 12.16.3 Aphena Pharma +C581Solutions Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.16.4 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio
- 12.16.5 Aphena Pharma +C581Solutions Recent Developments
- 12.17 NNE
- 12.17.1 NNE Company Information
- 12.17.2 NNE Business Overview
- 12.17.3 NNE Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.17.4 NNE Pharmaceutical Serialisation Services Product Portfolio
- 12.17.5 NNE Recent Developments
- 12.18 Sharp Services
- 12.18.1 Sharp Services Company Information
- 12.18.2 Sharp Services Business Overview
- 12.18.3 Sharp Services Revenue in Pharmaceutical Serialisation Services Business (2021-2026)
- 12.18.4 Sharp Services Pharmaceutical Serialisation Services Product Portfolio
- 12.18.5 Sharp Services Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst